An Evaluation of Omega-3 Status and Intake in Canadian Elite Rugby 7s Players.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
25 Oct 2021
Historique:
received: 13 09 2021
revised: 02 10 2021
accepted: 19 10 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 16 12 2021
Statut: epublish

Résumé

EPA and DHA n-3 FA play crucial roles in both neurological and cardiovascular health and high dietary intakes along with supplementation suggest potential neuroprotection and concussion recovery support. Rugby athletes have a high risk of repetitive sub-concussive head impacts which may lead to long-term neurological deficits, but there is a lack of research looking into n-3 FA status in rugby players. We examined the dietary n-3 FA intake through a FFQ and n-3 FA status by measuring the percentage of n-3 FA and O3I in elite Canadian Rugby 7s players to show distribution across O3I risk zones; high risk, <4%; intermediate risk, 4 to 8%; and low risk, >8%. n-3 FA profile and dietary intake as per FFQ were collected at the beginning of the 2017-2018 Rugby 7s season in male ( O3I averaged 4.54% ± 1.77, with female athlete scores slightly higher, and higher O3I scores in supplemented athletes (4.82% vs. 3.94%, Overall, despite supplementation, O3I score remained in the high-risk category in a proportion of athletes who met recommended n-3 FA dietary intakes, and non-supplemented athletes had a higher proportion of O3I scores in the high-risk category, suggesting that dietary intake alone may not be enough and athletes may require additional dietary and n-3 FA supplementation to reduce neurological and cardiovascular risk.

Sections du résumé

BACKGROUND BACKGROUND
EPA and DHA n-3 FA play crucial roles in both neurological and cardiovascular health and high dietary intakes along with supplementation suggest potential neuroprotection and concussion recovery support. Rugby athletes have a high risk of repetitive sub-concussive head impacts which may lead to long-term neurological deficits, but there is a lack of research looking into n-3 FA status in rugby players. We examined the dietary n-3 FA intake through a FFQ and n-3 FA status by measuring the percentage of n-3 FA and O3I in elite Canadian Rugby 7s players to show distribution across O3I risk zones; high risk, <4%; intermediate risk, 4 to 8%; and low risk, >8%.
METHODS METHODS
n-3 FA profile and dietary intake as per FFQ were collected at the beginning of the 2017-2018 Rugby 7s season in male (
RESULTS RESULTS
O3I averaged 4.54% ± 1.77, with female athlete scores slightly higher, and higher O3I scores in supplemented athletes (4.82% vs. 3.94%,
CONCLUSIONS CONCLUSIONS
Overall, despite supplementation, O3I score remained in the high-risk category in a proportion of athletes who met recommended n-3 FA dietary intakes, and non-supplemented athletes had a higher proportion of O3I scores in the high-risk category, suggesting that dietary intake alone may not be enough and athletes may require additional dietary and n-3 FA supplementation to reduce neurological and cardiovascular risk.

Identifiants

pubmed: 34836033
pii: nu13113777
doi: 10.3390/nu13113777
pmc: PMC8620970
pii:
doi:

Substances chimiques

Fatty Acids, Omega-3 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Brain Armor
ID : 000000

Références

J Athl Train. 2019 Jan;54(1):7-11
pubmed: 30645147
J Am Coll Surg. 2008 Aug;207(2):276-83
pubmed: 18656058
J Biol Chem. 1957 May;226(1):497-509
pubmed: 13428781
Sports Med. 2018 Apr;48(4):953-969
pubmed: 29349651
PLoS One. 2014 Jan 27;9(1):e86472
pubmed: 24475126
Br J Sports Med. 2015 Apr;49(7):478-83
pubmed: 24659504
Biochim Biophys Acta. 2015 Apr;1851(4):469-84
pubmed: 25149823
J Neurotrauma. 2016 Feb 15;33(4):390-402
pubmed: 26247583
Prostaglandins Leukot Essent Fatty Acids. 2021 May;168:102268
pubmed: 33831721
Med Sci Sports Exerc. 2016 Jul;48(7):1320-30
pubmed: 26829001
Am J Emerg Med. 2013 Jan;31(1):273.e5-8
pubmed: 22867826
Eur Heart J. 2016 Aug 1;37(29):2315-2381
pubmed: 27222591
Neuroscience. 2013 Sep 17;248:655-63
pubmed: 23811071
Br J Sports Med. 2017 Sep;51(17):1272-1278
pubmed: 28137789
Med Sci Sports Exerc. 2016 Jun;48(6):974-82
pubmed: 26765633
J Nutr Biochem. 2009 Sep;20(9):715-25
pubmed: 18805685
J Neurotrauma. 2007 Oct;24(10):1587-95
pubmed: 17970622
Br J Sports Med. 2018 Apr;52(7):439-455
pubmed: 29540367
J Neurotrauma. 2010 Sep;27(9):1617-24
pubmed: 20597639
J Acad Nutr Diet. 2014 Jan;114(1):136-53
pubmed: 24342605
J Am Diet Assoc. 2002 Nov;102(11):1621-30
pubmed: 12449285
PLoS One. 2020 Apr 29;15(4):e0228834
pubmed: 32348305
Nutrients. 2014 Feb 21;6(2):799-814
pubmed: 24566438
J Neurotrauma. 2011 Oct;28(10):2113-22
pubmed: 21851229
Am J Clin Nutr. 2006 Jun;83(6 Suppl):1467S-1476S
pubmed: 16841856
Nutr J. 2014 Apr 02;13:31
pubmed: 24694001
Int J Sport Nutr Exerc Metab. 2016 Dec;26(6):497-505
pubmed: 27098595
Curr Cardiol Rep. 2010 Nov;12(6):503-8
pubmed: 20809235
Health Rep. 2015 Nov;26(11):3-11
pubmed: 26583692
Sports Med. 2018 Mar;48(Suppl 1):39-52
pubmed: 29368186
Sports Med. 2014 Dec;44(12):1717-31
pubmed: 25138311
Nutr Metab (Lond). 2011 Jun 10;8:36
pubmed: 21663641
Prog Lipid Res. 2016 Jul;63:132-52
pubmed: 27216485
Int J Sport Nutr Exerc Metab. 2014 Oct;24(5):559-64
pubmed: 25203220
Am J Clin Nutr. 2021 Apr 6;113(4):993-1008
pubmed: 33675340
Restor Neurol Neurosci. 2013;31(5):647-59
pubmed: 23835930
Neurosurgery. 2011 Feb;68(2):474-81; discussion 481
pubmed: 21135750
Postgrad Med. 2019 May;131(4):268-277
pubmed: 31063407
J Am Diet Assoc. 2011 Jan;111(1):117-123.e1-2
pubmed: 21185973

Auteurs

Ashley Armstrong (A)

Canadian Sport Institute Pacific, Victoria, BC V9E 2C5, Canada.

Anthony J Anzalone (AJ)

Wake Forest School of Medicine, Winston-Salem, NC 27101, USA.

Wendy Pethick (W)

Canadian Sport Institute Pacific, Victoria, BC V9E 2C5, Canada.

Holly Murray (H)

Canadian Sport Institute Pacific, Victoria, BC V9E 2C5, Canada.

Dylan T Dahlquist (DT)

Red Bull Athlete Performance Center, Los Angeles, CA 90404, USA.

Andrew T Askow (AT)

Department of Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.

Jeffery L Heileson (JL)

Department of Health, Human Performance and Recreation, Baylor University, Waco, TX 76798, USA.

Lyn M Hillyer (LM)

Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, ON N1G 2W1, Canada.

David W L Ma (DWL)

Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, ON N1G 2W1, Canada.

Jonathan M Oliver (JM)

The Sport Science Center, Texas Christian University, Fort Worth, TX 76129, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH